atorvastatin has been researched along with Cognitive Decline in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 8 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JS; Kim, Y; Lee, J | 1 |
| Chamanara, M; Eslami, SM; Ghasemi, M; Khorshidi, L; Mirghazanfari, M; Mirjani, R; Nezhadi, A; Rashidian, A | 1 |
| Fang, F; Fang, Z; Li, J; Li, X; Li, Y; Wang, J; Wang, X | 1 |
| Bottiglieri, T; Fardo, DW; Johnson, SN; Qiao, Q; Rogers, CB; Sudduth, TL; Weekman, EM; Wilcock, DM; Xie, K | 1 |
| Amidzic, A; Tiro, N | 1 |
| Auger, F; Barus, R; Bergeron, S; Bongiovanni, A; Bordet, R; Chen, Y; Gautier, S; Jonneaux, A; Laloux, C; Leboullenger, C; Potey, C; Tardivel, M | 1 |
| Gao, Q; Gao, T; Guan, L; Hu, Y; Jiang, J; Li, T; Liu, P; Qiao, H; Sheng, W; Xue, X | 1 |
| Azab, SS; Gad, AM; Mounier, NM; Wahdan, SA | 1 |
| Auger, F; Barus, R; Bergeron, S; Bordet, R; Chen, Y; Cordonnier, C; Deguil, J; Durieux, N; Gautier, S; Pasquier, F; Potey, C; Ravasi, L; Skrobala, E | 1 |
| Chu, H; Sheng, X; Wang, S; Zhai, L; Zhang, G; Zhang, X; Zheng, W | 1 |
| Huang, D; Liu, H; Niu, T; Wang, K; Yang, J | 1 |
| Chen, Z; Li, C; Liu, A; Liu, H; Liu, L; Shi, Y; Wang, C; Wang, F; Zhang, J; Zhao, X; Zhou, D | 1 |
12 other study(ies) available for atorvastatin and Cognitive Decline
| Article | Year |
|---|---|
Atorvastatin-mediated rescue of cancer-related cognitive changes in combined anticancer therapies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Cell Proliferation; Cognitive Dysfunction; Computational Biology; Cytokines; Humans; Models, Biological; Neoplasms; Neoplastic Stem Cells; Signal Transduction; Trastuzumab; Tumor Cells, Cultured | 2021 |
Protective effects of atorvastatin and rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-induced spatial learning and memory impairment.
Topics: Animals; Apoptosis; Atorvastatin; Cognitive Dysfunction; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Rosuvastatin Calcium; Spatial Learning; Spatial Memory | 2021 |
Evaluation of the Effects of Folic Acid Combined with Atorvastatin on the Poststroke Cognitive Impairment by Low-Rank Matrix Denoising Algorithm-Based MRI Imaging.
Topics: Algorithms; Atorvastatin; Cognitive Dysfunction; Folic Acid; Humans; Ischemic Stroke; Magnetic Resonance Imaging; Stroke | 2022 |
Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes.
Topics: Alzheimer Disease; Animals; Atorvastatin; Cognition; Cognitive Dysfunction; Dementia, Vascular; Homocysteine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Mice | 2023 |
Kinking of Bilateral Internal Carotid Arteries as Cause of Cognitive Dysfunction.
Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Bosnia and Herzegovina; Bromazepam; Carotid Artery, Internal; Citalopram; Clopidogrel; Cognitive Dysfunction; Donepezil; Dopamine Agents; Fibrinolytic Agents; GABA Modulators; Humans; Male; Memantine; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2020 |
Beneficial effects of atorvastatin on sex-specific cognitive impairment induced by a cerebral microhaemorrhage in mice.
Topics: Animals; Atorvastatin; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Female; Hippocampus; Humans; Male; Memory; Mice; Mice, Inbred C57BL; Vascular Endothelial Growth Factor A | 2021 |
Atorvastatin attenuates surgery-induced BBB disruption and cognitive impairment partly by suppressing NF-κB pathway and NLRP3 inflammasome activation in aged mice.
Topics: Aging; Animals; Atorvastatin; Blood-Brain Barrier; Cognitive Dysfunction; Inflammasomes; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Surgical Procedures, Operative | 2021 |
Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.
Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Atorvastatin; Avoidance Learning; Cognitive Dysfunction; Dose-Response Relationship, Drug; Doxorubicin; Endoplasmic Reticulum Stress; Male; Neuroprotective Agents; Oxidative Stress; Rats; Signal Transduction | 2021 |
Role of cortical microbleeds in cognitive impairment: In vivo behavioral and imaging characterization of a novel murine model.
Topics: Animals; Atorvastatin; Brain; Cerebral Hemorrhage; Cognitive Dysfunction; Collagenases; Disease Models, Animal; Male; Mice; Positron Emission Tomography Computed Tomography | 2019 |
Atorvastatin Attenuates Cognitive Deficits and Neuroinflammation Induced by Aβ
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Atorvastatin; Cognitive Dysfunction; Male; Neuroprotective Agents; NF-kappa B; Peptide Fragments; Rats; Rats, Sprague-Dawley; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4 | 2018 |
Moderate- and Low-Dose of Atorvastatin Alleviate Cognition Impairment Induced by High-Fat Diet via Sirt1 Activation.
Topics: Animals; Antioxidants; Atorvastatin; Body Weight; Cognition; Cognitive Dysfunction; Diet, High-Fat; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress; Sirtuin 1 | 2019 |
Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Atorvastatin; Cognitive Dysfunction; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Transgenic; Peptide Fragments; Phosphorylation; Prefrontal Cortex; Presenilin-1; tau Proteins | 2016 |